Management of secretions in esophageal cancer patients with glycopyrrolate

Annals of Oncology

Volumn 8, Issue 2, 1997, Pages 198-199

  Rashid, H ^a   Long, J D ^a   Wadleigh, R G ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

esophageal neoplasms; glycopyrrolate; palliative treatment; secretions; sputum

Indexed keywords

GLYCOPYRRONIUM BROMIDE;

ARTICLE; CLINICAL ARTICLE; ESOPHAGUS CANCER; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAGASTRIC DRUG ADMINISTRATION; PALLIATIVE THERAPY; PRIORITY JOURNAL; SALIVATION DISORDER; SECRETION;

ESOPHAGEAL NEOPLASMS; EXUDATES AND TRANSUDATES; GLYCOPYRROLATE; HUMANS; MUSCARINIC ANTAGONISTS;

EID: 0031047583     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008256029462     Document Type: Article

References (12)

1. Coia LR, Sauter ER. Esophageal cancer. Curr Probl Cancer 1994; 18: 189-247.
2. Hsu JC, Wong CS, Chen TS, Chang CL. Comparison of the cardiovascular and antisialogogue effects among glycopyrrolate, scopolamine and atropine in man. Hsueh Tsa Chi 1986; 24: 39-44.
3. Benet LZ, Kroetz DL, Sheiner LB. Pharmacokinetics. In Hardman JG. Limbird LE, Molinoff PB et al. (eds): Goodman & Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill 1996: 3-27.
4. Cozanitis DA, Dundee JW, Khan MM. Comparative study of atropine and glycopyrrolate on suxamethonium-induced changes in cardiac rate and rhythm. Br J Anaesth 1980; 52: 291-3.
5. Franko BV, Alphin RS, Ward JW, Lunsford CD. Pharmacodynamic evaluation of glycopyrrolate in animals. Ann NY Acad Sci 1962; 99: 174-8.
6. Wyant GM, Kao E. Glycopyrrolate methobromide. I. Effect on salivary secretion. Can Anaesth Soc J 1974; 21: 230-41.
7. Proakis AG, Harris GB. Comparative penetration of glycopyrrolate and atropine across the blood-brain and placental barriers in anesthetized dogs. Anesthesiology 1978; 48: 339-44.
8. Brown JH, Taylor P. Muscarinic receptor agonists and antagonists. In Hardman JG, Limbird LE, Molinoff PB et al. (eds): Goodman & Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill 1996; 141-60.
9. Casey DA, DeFazio Jr JV, Vansickle K, Lippmann SB. Delirium. Quick recognition, careful evaluation, and appropriate treatment. Postgrad Med 1996; 100: 121-4, 125, 133-4.
10. Ali-Melkkila A, Kanto J, Iisalo E. Pharmacokinetics and related pharmacodynamics of anticholinergic drugs. Acta Anesthesiol Scand 1993; 37: 633-42.
11. Kaltiala E, Penttila A, Vapaatalo H, Larmi T. The fate of intravenous (3H)glycopyrrolate in man. J Pharm Pharmacol 1974; 26: 352-4.
12. Mirakhur RK, Dundee JW. Glycopyrrolate: Pharmacology and clinical use. Anaesthesia 1983; 38: 1195-1204.